Click here to view online. Add this email to your safelist.
AstraZeneca takes latest scientific advances in oncology to major US And European congresses
29 November 2016
AstraZeneca and its global biologics research and development arm, MedImmune, will continue the oncology momentum built during 2016 with a strong end-of-year presence at three major congresses.
|
|||||
|
|||||
|
For more information please visit astrazeneca.com. If you would like to unsubscribe please click here. |
